Vice President of Process Development and Technology Transfer
iBio CDMO LLC
Dr. Berquist is the Vice President of Process Development and Technology Transfer at iBio CDMO. He has been the group leader for downstream process development since 2013 and performed or directed all downstream process development activities ranging from early-stage feasibility through scale-up and manufacturing.
Prior to his career in downstream process development, Dr. Berquist was a research assistant professor in the College of Medicine at the Texas A&M Health Science Center (2011 to 2013) investigating aspects of eukaryotic DNA replication and repair. From 2006 to 2011, Dr. Berquist performed his post-doctoral studies in the Lab of Molecular Gerontology at the National Institute of Aging, a part of the National Institutes of Health. He examined the molecular mechanisms behind premature aging and cancer-prone diseases under Dr. David M. Wilson III and Dr. Vilhelm Bohr. He earned a doctorate in Molecular Medicine from the University of Maryland School of Medicine in 2006 performing his graduate work in the lab of Dr. Shiladitya DasSarma.
Dr. Berquist’s training has encompassed genome sequencing and annotation, comparative genomic analyses, bioinformatics, molecular biology, microbial genetics, mammalian cell culture, confocal microscopy, protein purification, protein biochemistry, protein characterization, and enzyme kinetics. He currently utilizes all his scientific training and knowledge to aid and execute the design and implementation of downstream purification schemes for the clients of iBio CDMO.
Dr. Berquist has authored more than 25 peer-reviewed papers and book chapters.